Testing the Clinical Dementia Rating Sum of Boxes as an Outcome for Dementia with Lewy Bodies Clinical Trials
Abstract Introduction Dementia with Lewy bodies (DLB), a common cause of dementia, has no FDA-approved therapies, and clinical trials to date have had limited ability to demonstrate efficacy. The lack of validated DLB-specific clinical trial outcomes may hinder these efforts. Here, we test whether t...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Adis, Springer Healthcare
2025-09-01
|
| Serie: | Neurology and Therapy |
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/s40120-025-00822-x |
| Taggar: |
Inga taggar, Lägg till första taggen!
|